BRPI0412522A - composição anti-parasìtica despejável - Google Patents

composição anti-parasìtica despejável

Info

Publication number
BRPI0412522A
BRPI0412522A BRPI0412522-3A BRPI0412522A BRPI0412522A BR PI0412522 A BRPI0412522 A BR PI0412522A BR PI0412522 A BRPI0412522 A BR PI0412522A BR PI0412522 A BRPI0412522 A BR PI0412522A
Authority
BR
Brazil
Prior art keywords
closantel
volume
composition
bioavailability
disposable anti
Prior art date
Application number
BRPI0412522-3A
Other languages
English (en)
Inventor
William Blakely
Lillian Cromie
Original Assignee
Norbrook Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norbrook Lab Ltd filed Critical Norbrook Lab Ltd
Publication of BRPI0412522A publication Critical patent/BRPI0412522A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/36—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids
    • A01N37/38—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system
    • A01N37/40—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing at least one carboxylic group or a thio analogue, or a derivative thereof, and a singly bound oxygen or sulfur atom attached to the same carbon skeleton, this oxygen or sulfur atom not being a member of a carboxylic group or of a thio analogue, or of a derivative thereof, e.g. hydroxy-carboxylic acids having at least one oxygen or sulfur atom attached to an aromatic ring system having at least one carboxylic group or a thio analogue, or a derivative thereof, and one oxygen or sulfur atom attached to the same aromatic ring system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/609—Amides, e.g. salicylamide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dentistry (AREA)
  • Environmental Sciences (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Pest Control & Pesticides (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Toxicology (AREA)
  • Road Paving Structures (AREA)

Abstract

"COMPOSIçãO ANTI-PARASìTICA DESPEJáVEL". Uma composição anti-parasiticida apresentada como um produto 'despejável' para o tratamento de animais infectados por parasitas que são conhecidos como sendo suscetíveis às salicilanilidas, especialmente o closantel, sozinho ou em conjunto com pelo menos um outro composto antiparasítico do tipo da avermectina ou da milbemicina e que oferece uma biodisponibilidade aumentada da salicilanilida, através do fornecimento de um sistema de administração composto de pelo menos 20% (volume/volume) de um ou mais álcoois, e opcionalmente, incluindo um radical polimérico escolhido do grupo consistindo de polivinilpirrolidona (PVP), copolímeros em bloco de polioxipropileno/polioxialquileno (poloxâmero) e polietileno glicóis (PEG), dessa forma melhorando a biodisponibilidade, por exemplo, de closantel (avaliado com relação aos níveis de plasma do sangue do closantel).
BRPI0412522-3A 2003-07-12 2004-07-12 composição anti-parasìtica despejável BRPI0412522A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0316377.1A GB0316377D0 (en) 2003-07-12 2003-07-12 Parasiticidal composition
PCT/GB2004/003006 WO2005007241A1 (en) 2003-07-12 2004-07-12 Parasiticidal composition

Publications (1)

Publication Number Publication Date
BRPI0412522A true BRPI0412522A (pt) 2006-09-19

Family

ID=27742085

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0412522-3A BRPI0412522A (pt) 2003-07-12 2004-07-12 composição anti-parasìtica despejável

Country Status (29)

Country Link
US (1) US8993546B2 (pt)
EP (2) EP2286876A1 (pt)
JP (1) JP4677405B2 (pt)
KR (1) KR101095419B1 (pt)
CN (1) CN1822880B (pt)
AP (1) AP2956A (pt)
AU (1) AU2004257450B2 (pt)
BR (1) BRPI0412522A (pt)
CA (1) CA2532199C (pt)
CR (1) CR8174A (pt)
DK (1) DK1646425T3 (pt)
EA (1) EA009602B1 (pt)
EC (1) ECSP066360A (pt)
ES (1) ES2390224T3 (pt)
GB (2) GB0316377D0 (pt)
GE (1) GEP20094648B (pt)
HK (1) HK1096621A1 (pt)
HR (1) HRP20120721T1 (pt)
IL (1) IL173057A (pt)
MX (1) MXPA06000135A (pt)
NO (1) NO336181B1 (pt)
NZ (1) NZ544973A (pt)
OA (1) OA13188A (pt)
PL (1) PL1646425T3 (pt)
PT (1) PT1646425E (pt)
SI (1) SI1646425T1 (pt)
TN (1) TNSN06006A1 (pt)
WO (1) WO2005007241A1 (pt)
ZA (1) ZA200600374B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
GB0501220D0 (en) * 2005-01-21 2005-03-02 Norbrook Lab Ltd Anthelmintic composition
GB0711957D0 (en) * 2007-06-21 2007-08-01 Syntopix Ltd Formulations
CN101693009B (zh) * 2009-10-27 2010-12-01 纽素乐必佳（天津）药业集团有限公司 牛羊用抗寄生虫病氯氰碘柳胺钠透皮溶液及其制备方法
FR2991173B1 (fr) 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
CN103720652B (zh) * 2014-01-07 2016-09-28 王玉万 用泊洛沙姆和油性介质制备含阿维菌素类药物注射剂
WO2019054967A2 (en) * 2017-03-15 2019-03-21 Verano Ilac Sanayi Ve Ticaret Anonim Sirketi VETERINARY COMPOSITION TO BE POURED COMPRISING EPRINOMECTIN
GB201715122D0 (en) * 2017-09-19 2017-11-01 Omnipharm Dev Ltd Topical anti-infective formulation
BR112021006821A2 (pt) * 2018-10-12 2021-07-13 Hovione Scientia Limited método de tratamento de inflamação e patologias oftálmicas, dispersão sólida, formulação farmacêutica, método de matar ácaros e kit

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2731386A (en) * 1951-09-06 1956-01-17 Wallace & Tiernan Company Inc Antifungal composition
US3798258A (en) * 1970-03-13 1974-03-19 Merck & Co Inc Salicylanilides
LU62350A1 (pt) * 1970-12-31 1972-08-23
US3950360A (en) 1972-06-08 1976-04-13 Sankyo Company Limited Antibiotic substances
US4005218A (en) 1975-03-18 1977-01-25 Janssen Pharmaceutica N.V. Antiparasitic salicylanilide derivatives
SE434277B (sv) 1976-04-19 1984-07-16 Merck & Co Inc Sett att framstella nya antihelmintiskt verkande foreningar genom odling av streptomyces avermitilis
US4201861A (en) 1977-10-03 1980-05-06 Merck & Co., Inc. Acyl derivatives of C-076 compounds
US4206205A (en) 1977-10-03 1980-06-03 Merck & Co., Inc. Monosaccharide and aglycone derivatives of C-076
US4199569A (en) 1977-10-03 1980-04-22 Merck & Co., Inc. Selective hydrogenation products of C-076 compounds and derivatives thereof
US4171314A (en) 1977-12-19 1979-10-16 Merck & Co., Inc. 13-Halo and 13-deoxy C-076 compounds
US4173571A (en) 1977-12-19 1979-11-06 Merck & Co., Inc. 13-Halo and 13-deoxy derivatives of C-076 compounds
NZ197796A (en) 1980-08-04 1984-11-09 Merck & Co Inc Stabilised aqueous formulations containing ivermectin
NZ210505A (en) 1983-12-22 1988-06-30 Merck & Co Inc Parasiticidal compositions containing avermectin or milbemycin derivatives
NZ335166A (en) 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
RU2033150C1 (ru) 1992-06-10 1995-04-20 Виктор Антонович Дриняев Препарат для лечения и профилактики псороптоза у животных "аверсект"
PL174488B1 (pl) * 1993-05-10 1998-08-31 Merck & Co Inc Preparat do zwalczania pasożytów zwierząt oraz sposób wytwarzania preparatu do zwalczania pasożytów zwierząt
WO1994027598A1 (en) * 1993-05-26 1994-12-08 Commonwealth Scientific And Industrial Research Organisation Antiparasitic compositions
NZ267366A (en) 1993-06-15 1996-12-20 Univ Australian Controlling fasciola and other helminths using a synergistic composition of at least two anthelmintic active drugs each being selected from a different class of drug
NZ248486A (en) * 1993-08-24 1996-07-26 Ashmont Holdings Limited Subst Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
FR2739778B1 (fr) * 1995-10-13 1997-12-12 Virbac Lab Formulation topique destinee a traiter la maladie de la douve du foie chez l'animal
RU2112508C1 (ru) 1995-12-26 1998-06-10 Писков Вячеслав Борисович Способ лечения и профилактики саркоптоидозов животных
RU2121831C1 (ru) 1997-08-01 1998-11-20 Анатолий Александрович Непоклонов Препарат для профилактики и лечения гиподерматоза крупного рогатого скота
AUPP105497A0 (en) * 1997-12-19 1998-01-15 Schering-Plough Animal Health Limited Aqueous insecticidal pour-on treatment
RU2129430C1 (ru) 1998-03-17 1999-04-27 Общество С Ограниченной Ответственностью "Вик - Здоровье Животных" Препарат для борьбы с экто- и эндопаразитами животных "сантомектин"
US6239119B1 (en) * 1998-04-27 2001-05-29 Medimmune Oncology, Inc. Topical administration of amifostine and related compounds
GB9816132D0 (en) * 1998-07-24 1998-09-23 Norbrook Lab Ltd Non-aqueous anthelmintic composition
GEP20012490B (en) 1999-10-21 2001-07-25 Robizon Bostashvili Means Against Demodicosis of Agricultural and Domestic Animals
US6340672B1 (en) * 2000-02-16 2002-01-22 Phoenix Scientific, Inc. Parasiticidal formulation and a method of making this formulation
US6399651B1 (en) * 2000-06-29 2002-06-04 L. Dean Parks Method of treating dermatoses using avermectin compound
AUPQ875700A0 (en) * 2000-07-13 2000-08-03 Reflex Research Limited Combination compositions
US7238680B2 (en) * 2001-06-01 2007-07-03 Rosen Steven E Topical compositions for veterinary uses
GB2386067A (en) * 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising an avermectin or milbemycin, plus a salicylanilide & a polymeric species
AU2003275779B2 (en) * 2002-11-11 2009-02-05 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition

Also Published As

Publication number Publication date
MXPA06000135A (es) 2006-04-07
EA009602B1 (ru) 2008-02-28
CA2532199C (en) 2012-05-15
ECSP066360A (es) 2006-10-31
GEP20094648B (en) 2009-03-25
TNSN06006A1 (en) 2007-10-03
PL1646425T3 (pl) 2013-01-31
CR8174A (es) 2006-10-05
DK1646425T3 (da) 2012-09-17
ZA200600374B (en) 2007-05-30
GB2403905B (en) 2005-12-14
KR20060113631A (ko) 2006-11-02
NO336181B1 (no) 2015-06-08
EP2286876A1 (en) 2011-02-23
HRP20120721T1 (hr) 2012-10-31
JP4677405B2 (ja) 2011-04-27
AP2956A (en) 2014-08-31
KR101095419B1 (ko) 2011-12-16
GB0316377D0 (en) 2003-08-13
PT1646425E (pt) 2012-10-31
AU2004257450A1 (en) 2005-01-27
GB2403905A (en) 2005-01-19
IL173057A (en) 2013-10-31
NZ544973A (en) 2008-09-26
EP1646425A1 (en) 2006-04-19
EP1646425B1 (en) 2012-08-22
WO2005007241A1 (en) 2005-01-27
AU2004257450B2 (en) 2008-08-28
NO20060676L (no) 2006-02-10
CN1822880B (zh) 2012-07-11
IL173057A0 (en) 2006-06-11
ES2390224T3 (es) 2012-11-07
OA13188A (en) 2006-12-13
CA2532199A1 (en) 2005-01-27
CN1822880A (zh) 2006-08-23
SI1646425T1 (sl) 2012-12-31
GB0415541D0 (en) 2004-08-11
US8993546B2 (en) 2015-03-31
WO2005007241A8 (en) 2005-03-10
AP2006003506A0 (en) 2006-02-28
EA200600237A1 (ru) 2006-06-30
US20060142216A1 (en) 2006-06-29
JP2007528866A (ja) 2007-10-18
HK1096621A1 (en) 2007-06-08

Similar Documents

Publication Publication Date Title
TNSN06006A1 (en) Parasiticidal composition
BRPI0306993B8 (pt) polímero de polialquilenoglicol ativado; composição; e uso de um composto na produção de um medicamento para o tratamento de esclerose múltipla ou infecção viral suscetível
BR0313060A (pt) Composições farmacêuticas aquosas de 2,6-diisopropilfenol
ATE270544T1 (de) Halbfeste arzneizubereitung enthaltend isotretinoin
BRPI0418251B8 (pt) fosfonatos, monofosfonamidatos, bisfosfonamidatos, e, composição farmacêutica os compreendendo
BR0016709A (pt) Agente antiadesão da flora patogênica da pele
DK1227126T3 (da) Gummisammensætning anvendt til en gummiprop til et medikament eller til en medicinsk behandling eller dets tævrbundne produkt
WO2008095040A3 (en) 2-5a derivatives and their use as anti-cancer, anti-viral and anti-parasitic agents
CY1109307T1 (el) Χρηση αδαπαλενιου για τη θεραπεια δερματολογικων διαταραχων
EA201000747A1 (ru) Система и способ трансдермальной доставки и способ получения системы трансдермальной доставки
CL2013000715A1 (es) Composicion farmaceutica que comprende (3s,11ar)-n-[(2,4-difluorofenil)metil]-2,3,5,7,11,11a-hexahidro-6-hidroxi-3-metil-5,7-dioxo-oxazolo[3,2-a]pirido[1,2-d]pirazin-8-carboxamida y un sistema de agente tensoactivo de polisorbato y polietilenglicol; metodo de tratamiento; y su uso para tratar o prevenir una infeccion por vih.
DE50211045D1 (de) Medizinische aerosolformulierungen
BRPI0519135A2 (pt) macrolÍdeos
EA201000085A1 (ru) dsPHK, ПРЕДНАЗНАЧЕННАЯ ДЛЯ ЛЕЧЕНИЯ ВИРУСНОЙ ИНФЕКЦИИ
EA200800360A1 (ru) Формуляции с высоким содержанием лекарства и дозированные формы
UY30790A1 (es) Combinacion de dos agentes antiparasitarios, en particular un derivado de 1-aril-4-ciclopropilpirazol y un agente antihelmintico y aplicaciones
PE20001338A1 (es) Uso de interleuquina 10 para el tratamiento de infecciones causadas por el virus de la hepatitis c
BRPI0418294A (pt) composições sólidas farmacêuticas estabilizadas de medicamentos de baixa solubilidade, poloxámeros e polìmeros estabilizantes
WO2005030109A3 (en) Regimen for the administration of rifamycin-class antibiotics
Kar et al. Exploring the potential of metal nanoparticles as a possible therapeutic adjunct for covid-19 infection
ATE491452T1 (de) Pharmazeutische zusammensetzung mit antipsychotischer, antidepressiver oder antiepileptischer wirkung mit verringerter nebenwirkung
AR038853A1 (es) Una composicion parasiticida inyectable
AR075428A1 (es) Formulacion de doramectina en dosis elevada
DE60134234D1 (de) Nukleinsäurekonstrukte, damit transformierte vaskuläre zellen, pharmezeutische zusammensetzungen und verfahren zur induktion der angiogenese
DK1815850T3 (da) Controlled release formular af valproinsyreforbindelse og dets derivater

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 11A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2314 DE 12-05-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61K 31/609 (2006.01), A61P 33/14 (2006.01), A61K